Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Virtual Incision gets $20mm in B+ round

12 Feb 2020

Executive Summary

Virtual Incision Corp. (developer of a miniaturized surgical robot) raised $20mm in its Series B+ financing led by returning shareholder Bluestem Capital, which was joined by other existing investor and first-time backers including Genesis Innovation Group. The company will use the proceeds for clinical and regulatory activities leading up to the eventual commercialization of its MIRA (Miniaturized In vivo Robotic Assistant). Virtual Incision concurrently filed the IDE application.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By